Glucagon-like peptide

America's Weight Problem - Where Is The Pharmaceutical Industry?  Dec 19, 2005
Medical News Today (press release), These anorectic hormones include; alpha-melanocyte-stimulating hormone (_-MSH)5, neurotensin6, and glucagon-like peptide-1 (GLP-1)7, etc. ...

Human Genome Sciences Receives Milestone Payment From ...  Jan 10, 2006
Yahoo! News (press release) GSK reached in October 2004, under which GSK acquired exclusive worldwide rights to develop and commercialize GSK716155 (albumin-glucagon-like peptide-1, GLP-1 ...

Human Genome Sciences Reports on Progress Toward Commercialization ...  Jan 10, 2006
PR Newswire (press release), PROGRESS OF OTHER PRODUCT OPPORTUNITIES GSK716155 (formerly known as Albugon), a novel long-acting form of glucagon-like peptide-1 (GLP-1) for use in the ...

The Skinny on Obesity Drugs  Dec 22, 2005
Motley Fool 2008. Blocking DDP-IV allows natural levels of glucagon-like peptide-1 (GLP-1) to increase, thereby boosting satiety and fat loss. ...

Stimulation of pancreatic b-cell replication by incretins involves ...  Dec 19, 2005
Journal of Endocrinology The incretin hormones, Glucagon-Like Peptide-1 (GLP-1) and Glucose-dependent Insulinotropic Peptide (GIP) have been suggested to act as b-cell growth factors ...

Exendin-4 induction of cyclin D1 expression in INS-1 b- cells ...  Dec 22, 2005
Journal of Endocrinology Glucagon-like peptide-1 (GLP-1) and its analog exendin-4 (EX) have been considered as a growth factor implicated in pancreatic islet mass increase and ß-cell ...